Vidyya Medical News Service
Volume 5 Issue 64 Published - 14:00 UTC 08:00 EST 5-Mar-2003 Next Update - 14:00 UTC 08:00 EST 6-Mar-2003
little clear gif used for spacer

US prepares soldiers for Iraq's chemical and biological weapons
US military officials expect Iraq to use chemical and biological weapons against US and allied forces in the event of a war. Iraq used both nerve and blistering agents against Iranian troops during the 1983–88 Iran-Iraq war and used chemical weapons on Kurdish Iraqi citizens in an attack on the Iraqi village of Halabja in 1988.  more

Do vaccines cause asthma, allergies or other chronic diseases? Reviews of scientific data offer reassurances on vaccine safety
Large scientific studies do not support claims that vaccines may cause chronic diseases such as asthma, multiple sclerosis, chronic arthritis and diabetes, according to a report in the March 2003 issue of Pediatrics.  more


The case: When “psychiatric” symptoms are not - Elderly man with delusions found to have metastatic cancer
The patient seemed to be suffering from psychosis and was treated accordingly. Further neurological examination revealed something else altogether. Did the delay in proper diagnosis harm the patient?  more

Study in large HMO found that infants discharged 1 day after birth fared as well as those with longer hospital stays
A new study sponsored by the Agency for Healthcare Research and Quality found no ill effects from discharging infants in a large Massachusetts HMO from the hospital 1 day after uncomplicated vaginal birth, compared with sending them home with their mothers 2 days after birth. But, because a sharp rise in hospital costs offset the savings realized by limiting postpartum stays to 1 day, the health plan's average per-delivery expenses decreased only $90 while this policy was in practice, according to the researchers who conducted the study. more

Not much knowledge available regarding testosterone replacement therapy
Testosterone replacement products, approved by the US Food and Drug Administration (FDA) for hypogonadism, or clinically low testosterone in otherwise healthy men, are arousing concern from researchers who question a lack of data on long-term safety. So great is the dearth of information, that the Institute of Medicine (IOM) has been called on to help design large-scale studies.  more

little clear gif used for a space